KANG [iKang Healthcare] SC 13G/A: (Name of Issuer) Class A Common Stock (Title

[(Name of Issuer) Class A Common Stock (Title of Class of Securities) (CUSIP Number) December 30, 2016 (Date of Event Which Requires Filing of this Statement) [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * CUSIP No. 1. NAMES OF REPORTING PERSONS 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A ]

AMC [AMC ENTERTAINMENT] 424B5: PROSPECTUS SUPPLEMENT $600.0 million AMC ENTERTAINMENT HOLDINGS, INC.

[PROSPECTUS SUPPLEMENT $600.0 million AMC ENTERTAINMENT HOLDINGS, INC. Class A Common Stock We are offering 19,047,619 shares of our Class A common stock. We intend to use the net proceeds from this offering to repay all outstanding indebtedness under our Bridge Loan Agreement (as defined herein) and]

By | 2017-02-10T03:48:26+00:00 February 9th, 2017|Categories: AMC, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

EDU [New Oriental Education & Technology] SC 13G: SCHEDULE 13G New Oriental Education & Technology Group

[SCHEDULE 13G New Oriental Education & Technology Group Inc. (Name of Issuer) ADR (Title of Class of Securities) G6470A108 (CUSIP Number) 12/31/16 (Date of Event Which Requires Filing of this Statement) ☑ Rule 13d-1(b) ☐ Rule 13d-1(c) ☐ Rule 13d-1(d) The remainder of this cover page shall be filled o]

By | 2017-02-10T03:49:14+00:00 February 9th, 2017|Categories: Chinese Stocks, EDU, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals] 8-K: FORM 8-K CURRENT REPORT Date of Report (Date

[FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): February 5, 2017 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Province]

By | 2017-02-10T03:50:39+00:00 February 9th, 2017|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

CCM [Concord Medical Services] SC 13E3: Execution Version Note Subscription Agreement among Morgancreek Investment

[Execution Version Note Subscription Agreement among Morgancreek Investment Holdings Limited and Mr. Jianyu Yang and Blue Ocean Structure Investment II Company Limited and Blue Ocean Project Fund II, LP Dated February 9, 2017 Table of Contents 1. Interpretations 2 2. The Notes 10 3. 12 4. 14 5.] [Cay]

CCM [Concord Medical Services] SC 13D/A: Joint Filing Agreement Remainder of this page is

[Joint Filing Agreement Remainder of this page is intentionally left blank [ Jianyu Yang Shanghai Hui Fu Science and Technology Development Co., Ltd. Bi Zhang Oakville Holdings Group Limited Cherrylane Investments Limited Zheng Cheng Shanghai Jian Qian Science and Technology Development Co., Ltd.] [E]

SINA [SINA] SC 13G: SCHEDULE 13G SINA Corporation COM G81477104 12/31/16 ☑

[SCHEDULE 13G SINA Corporation COM G81477104 12/31/16 ☑ Rule 13d-1(b) ☐ Rule 13d-1(c) ☐ Rule 13d-1(d) The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing ]

By | 2017-02-10T03:54:06+00:00 February 9th, 2017|Categories: Chinese Stocks, SINA, Webplus ver|Tags: , , , , , |0 Comments

SYUT [Synutra International] 8-K: Synutra Reports Third Quarter Fiscal 2017 Financial Results

[Synutra Reports Third Quarter Fiscal 2017 Financial Results ~3Q17 Net Sales of $109.1 million ~3Q17 Nutritional Food sales of $98.0 million Qingdao, China and Rockville, Md. – February 9, 2017 – Synutra International, Inc. (Nasdaq: SYUT), (“Synutra” or the “Company”), which owns subsidiaries in Chin]

By | 2017-02-10T03:54:42+00:00 February 9th, 2017|Categories: Chinese Stocks, SYUT, Webplus ver|Tags: , , , , , |0 Comments

SYUT [Synutra International] 10-Q:

[] [CERTIFICATION I, Liang Zhang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Synutra International, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, ]

By | 2017-02-10T03:55:39+00:00 February 9th, 2017|Categories: Chinese Stocks, SYUT, Webplus ver|Tags: , , , , , |0 Comments

IDI [Cogint] 424B3: PROSPECTUS 1,300,000 Shares of Common Stock Risk Factors

[PROSPECTUS 1,300,000 Shares of Common Stock Risk Factors The common stock offered in this prospectus involves a high degree of risk. See “ No underwriter or other person has been engaged to facilitate the sale of shares of our common stock in this offering. Each selling shareholder may be deemed an ]

By | 2017-02-10T03:56:11+00:00 February 9th, 2017|Categories: Chinese Stocks, IDI, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar